Men who consume a higher amount of whole grain breakfast cereals may have a reduced risk of heart failure, according to a report in the October 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Although medication can help extend the lives of men with chronic heart failure, several factors associated with this disease can interfere with a person’s ability to engage in and enjoy sexual activities. Fatigue, depression, medication side effects and the fear of damaging the heart can cause people with chronic heart failure to lose interest in sex or wonder whether this activity is safe for them.

Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need – especially women and minorities, say researchers at Duke University Medical Center.

An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia®) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues.

A meta-analysis of previous research suggests that use of pioglitazone, a glycemic control medication for patients with type 2 diabetes, significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the September 12 issue of JAMA.

Preliminary findings indicate a heart failure medication used by adults, carvedilol, may not significantly improve heart failure outcomes for children and adolescents, according to an article in the September 12 issue of JAMA.

Drugs that are agonists of the receptor PPAR-gamma are used to treat individuals with diabetes. However, it has been suggested that their use is associated with a slightly increased risk of heart failure.

New data generated by Howard Rockman and colleagues at Duke University Medical Center, have identified a new signaling pathway downstream of the beta1-adrenergic receptor in the heart that protects the muscle cells of the heart from dying. The potential clinical impact of these observations is discussed in the accompanying commentary by Stefan Englehardt from the University of WÃlrzburg, Germany.

The U.S. Food and Drug Administration today (August 14) announced manufacturers of certain drugs approved to treat Type 2 diabetes have agreed to add a stronger warning on the risk of heart failure, a condition that occurs when the heart does not adequately pump blood.

Patients suffering from obstructive sleep apnea (OSA) and diastolic heart failure may find relief in the form of diuretics, according to a new study.

Many people with long-standing high blood pressure develop heart failure. But some don't. Daniel P. Kelly, M.D., and colleagues at Washington University School of Medicine in St. Louis and other institutions are trying to figure out what could explain that difference.